Cerion Nanomaterials, a leader in the science of nanomaterial design, scale-up and manufacturing, will be exhibiting at Photonics West including the BiOs Expo in February 2020.

Photonics West along with the BiOS Expo is billed as “The Leading Event for the Photonics and Laser Communities”, the event combines a full week schedule of learnings, workshops and networking opportunities for companies in industry and life sciences to access the latest research in biophotonics, laser technologies, and optoelectronics materials and devices.

Cerion will join this community of researchers, scientists, engineers and technology developers to exhibit its capabilities in designing, scaling and manufacturing inorganic nanomaterials.

Cerion will highlight how companies from around the globe utilize its services across the spectrum of product development to produce customized nanomaterials used in optics, photonics, laser and imaging products.

BiOS Expo will be held from February 1-2, 2020 in San Francisco, California.  Topics include biomedical optics, diagnostics and therapeutics, biophotonics, new imaging modalities, optical coherence tomography, neurophotonics, optogenetics, tissue optics, and nanophotonics.

Photonics West will be held from February 4-6, 2020 in San Francisco, California. It is a key event for the photonics and laser communities, that provides access to the latest research and products in biophotonics, laser technologies and optoelectronics.

About Cerion Nanomaterials

Cerion is a leader in the science of designing, scaling and manufacturing metal, metal oxide and ceramic nanomaterials for companies developing products.

The cost of developing advanced expertise in nanomaterials is prohibitively expensive and time intensive, resulting in a significant barrier to entry for companies considering its adoption. Cerion provides companies with access to this expertise through all phases of the product life cycle including applied research, development, scale-up, commercialization and manufacturing.

Cerion’s position in the market is enabled by three strategic competitive advantages: deep and demonstrated capability in a.) precision design and customization of both nanoparticle size and technical attributes, b.) robust processes to scale materials from prototype to low and high-volume production rates, and c.) industry-leading, cost-effective manufacturing systems and production capacities.